Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Activation of Coagulation Pathways in Clinical Renal Allotransplantation and Delayed Graft Function and Acute Rejection of the Graft

NCT02568696 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT02568696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02568696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Activation of Coagulation Pathways in Clinical Renal Allotransplantation and Delayed Graft Function and Acute Rejection of the Graft
Lead sponsor
Helsinki University Central Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2015
Completion date
December 31, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delayed graft function, end stage renal disease, kidney transplantation, reperfusion injury